1Bateman ED,Boushey HA,Bousquet J,et al.Can guideline-defined asthma control be achieved? The gaining Optimal Asthma Control Study.Am J Respir Crit Care Med,2004,170:836-844.
2WHO/NHLBI Workshop Report.Global initiative for asthma management and prevention.Maryhland:National Institute of Health,National Heart,Lung,and Blood Institute,2006:20-70.
3Nathan RA,Sorkness CA,Kosinski M,Schatz M,et al.Development of the asthma control test:a survey for assessing asthma control.J Allergy Clin Immunol,2004,113:59-65.
4Juniper EF,Bousquet J,Abetz L,Bateman ED.Identifying "well-controlled" and "not well-controlled" asthma using the Asthma Control Questionnaire.Respir Med,2006,100:616-621.
5Vollmer WM,Markson LE,O'Connor E,et al.Association of asthma control with health care utilization and quality of life.Am J Respir Crit Care Med,1999,160(5Pt 1):1647-1652.
6Boulet LP,Boulet V,Milot J.How should we quantify asthma control? A proposal.Chest,2002,122:2217-2223.
7O'Byrne PM,Barnes PJ,Rodriguez-Roisin R,et al.Low dose inhaled budesonide and formoterol in mild persistent asthma:the OPTIMA randomized trial.Am J Respir Crit Care Med,2001,164(8 Pt 1):1392-1397.
8Lemanske RF Jr,Sorkness CA,Mauger EA,et al.Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol:a randomized controlled trial.JAMA,2001,285:2594-2603.
9Boulet LP,Drollmann A,Magyar P,et al.Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma.Respir Med,2006,100:785-794.
10Bateman ED,Fairall L,Lombardi DM,English R.Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol.Respir Res,2006,7:13-21.
